By the time you read this, I'll be 30,000ft somewhere between New York and San Diego on the way to the American Association of Cancer Research (AACR) meeting being held in California on the molecular origins of lung cancer.
I'm planning on posting some highlights and insights daily by the end of the evening or first thing the next morning at the very latest. Some tweets of key points may also appear from Tuesday morning PST – you can follow them on Twitter using the #AACR hashtag, if so inclined. AACR also has an official Twitter account (@AACR).
Some of the topics I'm particularly interested include microRNA profiling for resistance in small cell lung cancer (SCLC), a session on insulin-like growth factor receptor (IGF-1R) signalling, updates on an ALK inhibitor, gefitinib (Iressa) and other sessions.
Watch this space!